Formulations for oral delivery of adsorbents in the gut
US11202761B2 · kind B2 · utility
0Cited by
13References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 26, 2018 |
| Grant date | Dec 21, 2021 |
| Priority date | — |
| Expiry date | Dec 6, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a formulation for the delayed and controlled delivery of an adsorbent into the lower intestine of mammals. The formulation includes a carrageenan and an adsorbent, such as activated charcoal. The invention further relates to uses of this formulation, in particular to pharmaceutical uses. In one embodiment, the formulation is used to eliminate or reduce the side effects in the intestine, in particular in the colon, of pharmaceutical agents that are administered as a treatment for a disorder, but that have side effects when they reach the late ileum, the caecum or the colon.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.